Business article - March 12, 2025
Boule Diagnostics closes BM950 project and announces new portfolio strategy
Boule Diagnostics announces the decision to close the BM950 project due to newly identified technical issues that have significantly impacted the project’s time to market and overall profitability.
Business article - March 5, 2025
Zelluna announces the successful completion of a business combination
All conditions for completion of the business combination have been met, including, confirmation by Euronext Oslo Børs of the continued listing, approval of the prospectus and regulatory clearances, the new company states.
Biotech Business - February 5, 2025
Aqilion resumes development of its TAK1-program
The company has resumed development of the its TAK1 program as the company has regained the control and ownership of the program.
Business article - December 20, 2024
Life sciences in Umeå is highlighted in new documentary
Journalist and documentary filmmaker Luis Jachmann has visited North Sweden to document Umeå’s role as a life science hub.
Acquisition - December 18, 2024
Ultimovacs combines its business with Zelluna Immunotherapy
Ultimovacs and Zelluna Immunotherapy have announced that Ultimovacs and shareholders of Zelluna representing more than 99% of the total number of issued and outstanding shares in Zelluna have entered into a definitive business combination agreement to combine the two companies in a share exchange transaction.
Business article - December 17, 2024
Key takeaways from the EU HTA panel discussion in Finland
With just months to go before the EU joint clinical assessment (JCA) process takes effect, the focus on what it will mean from a country perspective is intensifying.
